0001468328 Addus HomeCare Corp false --12-31 Q1 2026 0.001 0.001 40,000 40,000 18,665 18,665 18,518 18,518 3 3 1.6 1 20 3 15 3 15 1 20 3 5 6 10 2.3 http://fasb.org/us-gaap/2026#GeneralAndAdministrativeExpense July 30, 2028 3.75 4.25 0 http://fasb.org/srt/2026#ChiefExecutiveOfficerMember 3 3 The Company’s method for measuring profitability on each reportable segment basis is the same as those described in the summary of significant accounting policies and its CODMs frequently review the actual result to budget variance to allocate resources to the segment and assess its performance. Segment operating income consists of revenue generated by a segment, less the direct costs of service revenues and general and administrative expenses that are incurred directly by the segment. Unallocated general and administrative costs are those costs for functions performed in a centralized manner and therefore not attributable to a particular segment. These costs include accounting, finance, human resources, legal, information technology, corporate office support and facility costs and overall corporate management. true true true true true true true true true true Roberton Stevenson EVP and Chief Human Resources Officer March 5, 2026 February 23, 2027 3,521 Michael Wattenbarger EVP and Chief Information Officer March 3, 2026 February 23, 2027 3,852 R. Dirk Allison Chief Executive Officer and Chairman of the Board March 2, 2026 February 23, 2027 32,492 Darby Anderson EVP and Chief Government Affairs & Community Relations Officer March 3, 2026 February 23, 2027 4,901 Heather Brianne Dixon President and Chief Operating Officer March 6, 2026 September 15, 2027 13,614 Cliff Blessing EVP and Chief Development Officer March 6, 2026 February 23, 2027 3,521 Brian Poff EVP, Chief Financial Officer, Secretary and Treasurer March 2, 2026 February 23, 2027 13,101 Monica Raines EVP and Chief Compliance and Quality Officer March 5, 2026 February 23, 2027 3,521 Sean Gaffney EVP and Chief Legal Officer March 5, 2026 February 23, 2027 4,901 David Tucker EVP and Chief Strategy Officer March 5, 2026 February 23, 2027 4,277 false false false Other segment items include other costs for direct service personnel, office expense, licenses & taxes, communication, medical director fees, travel and bad debt expense. As a result of changes and uncertainty in New York regarding the CDPAP, the Company determined that its New York personal care operations no longer fit its growth strategy and is divesting these operations. See Note 3 to the Notes to Unaudited Condensed Consolidated Financial Statements, Divestiture, for additional details regarding our divestiture. Included $2.3 million related to the New York Asset Sale deferred payments as of March 31, 2026 and December 31, 2025, respectively. 00014683282026-01-012026-03-31 xbrli:shares 00014683282026-04-28 thunderdome:item iso4217:USD 00014683282026-03-31 00014683282025-12-31 iso4217:USDxbrli:shares 00014683282025-01-012025-03-31 0001468328us-gaap:CommonStockMember2025-12-31 0001468328us-gaap:AdditionalPaidInCapitalMember2025-12-31 0001468328us-gaap:RetainedEarningsMember2025-12-31 0001468328us-gaap:CommonStockMember2026-01-012026-03-31 0001468328us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-31 0001468328us-gaap:RetainedEarningsMember2026-01-012026-03-31 0001468328us-gaap:CommonStockMember2026-03-31 0001468328us-gaap:AdditionalPaidInCapitalMember2026-03-31 0001468328us-gaap:RetainedEarningsMember2026-03-31 0001468328us-gaap:CommonStockMember2024-12-31 0001468328us-gaap:AdditionalPaidInCapitalMember2024-12-31 0001468328us-gaap:RetainedEarningsMember2024-12-31 00014683282024-12-31 0001468328us-gaap:CommonStockMember2025-01-012025-03-31 0001468328us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-31 0001468328us-gaap:RetainedEarningsMember2025-01-012025-03-31 0001468328us-gaap:CommonStockMember2025-03-31 0001468328us-gaap:AdditionalPaidInCapitalMember2025-03-31 0001468328us-gaap:RetainedEarningsMember2025-03-31 00014683282025-03-31 xbrli:pure 0001468328us-gaap:EmployeeStockOptionMember2026-01-012026-03-31 0001468328us-gaap:EmployeeStockOptionMember2025-01-012025-03-31 0001468328us-gaap:RestrictedStockMember2026-01-012026-03-31 0001468328us-gaap:RestrictedStockMember2025-01-012025-03-31 0001468328adus:NewYorkAssetSaleMember2024-05-20 0001468328adus:NewYorkAssetSaleMember2024-05-202024-05-20 0001468328adus:NewYorkAssetSaleMember2024-10-012024-10-31 0001468328adus:NewYorkAssetSaleMember2024-01-012024-12-31 0001468328adus:NewYorkAssetSaleMember2026-01-012026-03-31 utr:Y 0001468328adus:HospiceSegmentMember2025-12-31 0001468328adus:PersonalCareSegmentMember2025-12-31 0001468328adus:HomeHealthSegmentMember2025-12-31 0001468328adus:HospiceSegmentMember2026-01-012026-03-31 0001468328adus:PersonalCareSegmentMember2026-01-012026-03-31 0001468328adus:HomeHealthSegmentMember2026-01-012026-03-31 0001468328adus:HospiceSegmentMember2026-03-31 0001468328adus:PersonalCareSegmentMember2026-03-31 0001468328adus:HomeHealthSegmentMember2026-03-31 0001468328srt:MinimumMember2026-03-31 0001468328srt:MaximumMember2026-03-31 0001468328us-gaap:CustomerRelationshipsMembersrt:MinimumMember2026-03-31 0001468328us-gaap:CustomerRelationshipsMembersrt:MaximumMember2026-03-31 0001468328us-gaap:CustomerRelationshipsMember2026-03-31 0001468328us-gaap:CustomerRelationshipsMember2025-12-31 0001468328us-gaap:TrademarksAndTradeNamesMembersrt:MinimumMember2026-03-31 0001468328us-gaap:TrademarksAndTradeNamesMembersrt:MaximumMember2026-03-31 0001468328us-gaap:TrademarksAndTradeNamesMember2026-03-31 0001468328us-gaap:TrademarksAndTradeNamesMember2025-12-31 0001468328us-gaap:NoncompeteAgreementsMembersrt:MinimumMember2026-03-31 0001468328us-gaap:NoncompeteAgreementsMembersrt:MaximumMember2026-03-31 0001468328us-gaap:NoncompeteAgreementsMember2026-03-31 0001468328us-gaap:NoncompeteAgreementsMember2025-12-31 0001468328adus:StateLicensesMembersrt:MinimumMember2026-03-31 0001468328adus:StateLicensesMembersrt:MaximumMember2026-03-31 0001468328adus:StateLicensesMember2026-03-31 0001468328adus:StateLicensesMember2025-12-31 0001468328adus:StateLicensesMember2026-03-31 0001468328adus:StateLicensesMember2025-12-31 0001468328adus:NewYorkAssetSaleMember2026-03-31 0001468328adus:NewYorkAssetSaleMember2025-12-31 0001468328us-gaap:RevolvingCreditFacilityMemberadus:CapitalOneNationalAssociationMember2026-03-31 0001468328us-gaap:RevolvingCreditFacilityMemberadus:CapitalOneNationalAssociationMember2025-12-31 0001468328us-gaap:RevolvingCreditFacilityMemberadus:CapitalOneNationalAssociationMember2024-10-22 0001468328adus:CreditAgreementMember2024-10-22 0001468328adus:CreditAgreementMember2024-10-222024-10-22 0001468328us-gaap:RevolvingCreditFacilityMemberadus:CapitalOneNationalAssociationMembersrt:MinimumMemberus-gaap:PrimeRateMember2024-10-222024-10-22 0001468328us-gaap:RevolvingCreditFacilityMemberadus:CapitalOneNationalAssociationMembersrt:MaximumMemberus-gaap:PrimeRateMember2024-10-222024-10-22 0001468328us-gaap:RevolvingCreditFacilityMemberadus:CapitalOneNationalAssociationMemberadus:FederalFundsRateMember2024-10-222024-10-22 0001468328us-gaap:RevolvingCreditFacilityMemberadus:CapitalOneNationalAssociationMembersrt:MinimumMember2024-10-22 0001468328us-gaap:RevolvingCreditFacilityMemberadus:CapitalOneNationalAssociationMembersrt:WeightedAverageMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-10-22 0001468328adus:CreditAgreementMembersrt:MinimumMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-10-222024-10-22 0001468328adus:CreditAgreementMembersrt:MaximumMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-10-222024-10-22 0001468328adus:CreditAgreementMembersrt:MinimumMember2024-10-22 0001468328us-gaap:RevolvingCreditFacilityMemberadus:CapitalOneNationalAssociationMembersrt:MaximumMember2024-10-22 0001468328us-gaap:RevolvingCreditFacilityMemberadus:CapitalOneNationalAssociationMember2026-01-012026-03-31 0001468328us-gaap:OperatingSegmentsMemberadus:PersonalCareMember2026-01-012026-03-31 0001468328us-gaap:OperatingSegmentsMemberadus:HospiceMember2026-01-012026-03-31 0001468328us-gaap:OperatingSegmentsMemberadus:HomeHealthMember2026-01-012026-03-31 0001468328us-gaap:OperatingSegmentsMember2026-01-012026-03-31 0001468328us-gaap:OperatingSegmentsMemberadus:PersonalCareMember2025-01-012025-03-31 0001468328us-gaap:OperatingSegmentsMemberadus:HospiceMember2025-01-012025-03-31 0001468328us-gaap:OperatingSegmentsMemberadus:HomeHealthMember2025-01-012025-03-31 0001468328us-gaap:OperatingSegmentsMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:StateLocalAndOtherGovernmentalProgramsMemberadus:PersonalCareSegmentMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:StateLocalAndOtherGovernmentalProgramsMemberadus:PersonalCareSegmentMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:ManagedCareOrganizationsMemberadus:PersonalCareSegmentMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:ManagedCareOrganizationsMemberadus:PersonalCareSegmentMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:PrivatePayMemberadus:PersonalCareSegmentMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:PrivatePayMemberadus:PersonalCareSegmentMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:CommercialInsuranceMemberadus:PersonalCareSegmentMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:CommercialInsuranceMemberadus:PersonalCareSegmentMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:OtherMemberadus:PersonalCareSegmentMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:OtherMemberadus:PersonalCareSegmentMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:PersonalCareSegmentMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:PersonalCareSegmentMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:MedicareMemberadus:HospiceSegmentMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:MedicareMemberadus:HospiceSegmentMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:CommercialInsuranceMemberadus:HospiceSegmentMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:CommercialInsuranceMemberadus:HospiceSegmentMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:ManagedCareOrganizationsMemberadus:HospiceSegmentMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:ManagedCareOrganizationsMemberadus:HospiceSegmentMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:OtherMemberadus:HospiceSegmentMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:OtherMemberadus:HospiceSegmentMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:HospiceSegmentMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:HospiceSegmentMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:MedicareMemberadus:HomeHealthSegmentMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:MedicareMemberadus:HomeHealthSegmentMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:ManagedCareOrganizationsMemberadus:HomeHealthSegmentMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:ManagedCareOrganizationsMemberadus:HomeHealthSegmentMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:StateLocalAndOtherGovernmentalProgramsExcludingMedicareMemberadus:HomeHealthSegmentMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:StateLocalAndOtherGovernmentalProgramsExcludingMedicareMemberadus:HomeHealthSegmentMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:OtherMemberadus:HomeHealthSegmentMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:OtherMemberadus:HomeHealthSegmentMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:HomeHealthSegmentMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:HomeHealthSegmentMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberstpr:IL2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberstpr:IL2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberstpr:TX2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberstpr:TX2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberstpr:NM2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberstpr:NM2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberstpr:NY2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberstpr:NY2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberadus:AllOtherStatesMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberadus:AllOtherStatesMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberstpr:OH2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberstpr:OH2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberstpr:IL2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberstpr:IL2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberstpr:NM2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberstpr:NM2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberadus:AllOtherStatesMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberadus:AllOtherStatesMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMemberstpr:NM2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMemberstpr:NM2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMemberstpr:TN2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMemberstpr:TN2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMemberstpr:IL2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMemberstpr:IL2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMember2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMemberstpr:IL2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMemberstpr:IL2025-01-012025-03-31 0001468328us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberadus:IllinoisDepartmentOnAgingMember2026-01-012026-03-31 0001468328us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberadus:IllinoisDepartmentOnAgingMember2025-01-012025-03-31 0001468328us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberadus:IllinoisDepartmentOnAgingMember2026-01-012026-03-31 0001468328us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberadus:IllinoisDepartmentOnAgingMember2025-01-012025-12-31 0001468328adus:HomecourtAcquisitionMemberus-gaap:SubsequentEventMember2026-04-012026-04-01 0001468328adus:RobertonStevensonMember2026-01-012026-03-31 0001468328adus:MichaelWattenbargerMember2026-01-012026-03-31 0001468328adus:RDirkAllisonMember2026-01-012026-03-31 0001468328adus:DarbyAndersonMember2026-01-012026-03-31 0001468328adus:HeatherBrianneDixonMember2026-01-012026-03-31 0001468328adus:CliffBlessingMember2026-01-012026-03-31 0001468328adus:BrianPoffMember2026-01-012026-03-31 0001468328adus:MonicaRainesMember2026-01-012026-03-31 0001468328adus:SeanGaffneyMember2026-01-012026-03-31 0001468328adus:DavidTuckerMember2026-01-012026-03-31 0001468328adus:RobertonStevensonMember2026-03-31 0001468328adus:MichaelWattenbargerMember2026-03-31 0001468328adus:RDirkAllisonMember2026-03-31 0001468328adus:DarbyAndersonMember2026-03-31 0001468328adus:HeatherBrianneDixonMember2026-03-31 0001468328adus:CliffBlessingMember2026-03-31 0001468328adus:BrianPoffMember2026-03-31 0001468328adus:MonicaRainesMember2026-03-31 0001468328adus:SeanGaffneyMember2026-03-31 0001468328adus:DavidTuckerMember2026-03-31

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2026

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 001-34504

ADDUS HOMECARE CORPORATION

(Exact name of registrant as specified in its charter)


Delaware	20-5340172
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

6303 Cowboys Way, Suite 600 Frisco, TX	75034
(Address of principal executive offices)	(Zip Code)

(469) 535-8200

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.001 par value	ADUS	The Nasdaq Stock Market, LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Table of Contents

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer	☒	Accelerated Filer	☐
Non-Accelerated Filer	☐	Smaller Reporting Company	☐
Emerging Growth Company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of April 28, 2026, Addus HomeCare Corporation had 18,664,776 shares of Common Stock outstanding.

Table of Contents

ADDUS HOMECARE CORPORATION

FORM 10-Q

INDEX

PART I. FINANCIAL INFORMATION	4

Item 1. Financial Statements (Unaudited)	4

Condensed Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025	4

Condensed Consolidated Statements of Income For the Three Months Ended March 31, 2026 and 2025	5

Condensed Consolidated Statement of Stockholders’ Equity For the Three Months Ended March 31, 2026 and 2025	6

Condensed Consolidated Statements of Cash Flows For the Three Months Ended March 31, 2026 and 2025	8

Notes to Condensed Consolidated Financial Statements	9

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	21

Item 3. Quantitative and Qualitative Disclosures About Market Risk	34

Item 4. Controls and Procedures	35

PART II. OTHER INFORMATION	36

Item 1. Legal Proceedings	36

Item 1A. Risk Factors	36

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	36

Item 3. Defaults Upon Senior Securities	36

Item 4. Mine Safety Disclosures	36

Item 5. Other Information	37

Item 6. Exhibits	38

Table of Contents

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

As of March 31, 2026 and December 31, 2025

(Amounts and Shares in Thousands, Except Per Share Data)

(Unaudited)

	*March 31, 2026*		*December 31, 2025*
Assets
Current assets
Cash	$	103,065	$	81,617
Accounts receivable, net of allowances for credit losses		144,823		151,695
Prepaid expenses and other current assets		24,988		36,179
Total current assets		272,876		269,491
Property and equipment, net of accumulated depreciation and amortization		24,657		24,998
Other assets
Goodwill		996,680		996,696
Intangibles, net of accumulated amortization		100,488		102,410
Operating lease assets, net		40,999		43,713
Total other assets		1,138,167		1,142,819
Total assets	$	1,435,700	$	1,437,308
Liabilities and stockholders' equity
Current liabilities
Accounts payable	$	14,040	$	16,832
Accrued payroll		63,926		65,941
Accrued expenses		30,348		28,191
Operating lease liabilities, current portion		13,139		13,144
Government stimulus advances		14,637		11,699
Accrued workers' compensation insurance		13,385		13,680
Total current liabilities		149,475		149,487
Long-term liabilities
Long-term debt, net of debt issuance costs		91,274		120,959
Long-term operating lease liabilities		34,331		37,259
Deferred income tax		44,205		44,065
Other long-term liabilities		255		235
Total long-term liabilities		170,065		202,518
Total liabilities	$	319,540	$	352,005
Stockholders' equity
Common stock—$.001 par value; 40,000 authorized and 18,665 and 18,518 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$	19	$	18
Additional paid-in capital		618,732		612,945
Retained earnings		497,409		472,340
Total stockholders' equity		1,116,160		1,085,303
Total liabilities and stockholders' equity	$	1,435,700	$	1,437,308

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

For the Three Months Ended March 31, 2026 and 2025

(Amounts and Shares in Thousands, Except Per Share Data)

(Unaudited)

	*For the Three Months Ended*
	*March 31,*
	*2026*			*2025*
Net service revenues	$	363,611		$	337,708
Cost of service revenues		247,738			230,031
Gross profit		115,873			107,677
General and administrative expenses		77,771			73,220
Depreciation and amortization		4,030			3,943
Total operating expenses		81,801			77,163
Operating income		34,072			30,514
Interest income		(510	)		(502	)
Interest expense		2,151			4,018
Total interest expense, net		1,641			3,516
Income before income taxes		32,431			26,998
Income tax expense		7,362			5,770
Net income	$	25,069		$	21,228
Net income per common share
Basic income per share	$	1.38		$	1.18
Diluted income per share	$	1.36		$	1.16
Weighted average number of common shares and potential common shares outstanding:
Basic		18,194			17,976
Diluted		18,486			18,311

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

For the Three Months Ended March 31, 2026

(Amounts and Shares in Thousands)

(Unaudited)

	*For the Three Months Ended March 31, 2026*
						*Additional*				*Total*
	*Common Stock*					*Paid-in*		*Retained*		*Stockholders'*
	*Shares*			*Amount*		*Capital*		*Earnings*		*Equity*
Balance at January 1, 2026		18,518		$	18	$	612,945	$	472,340	$	1,085,303
Issuance of shares of common stock under restricted stock award agreements		126			1		—		—		1
Forfeiture of shares of common stock under restricted stock award agreements		(1	)		—		—		—		—
Stock-based compensation		—			—		5,000		—		5,000
Shares issued for exercise of stock options		21			—		787		—		787
Net income		—			—		—		25,069		25,069
Balance at March 31, 2026		18,664		$	19	$	618,732	$	497,409	$	1,116,160

Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

For the Three Months Ended March 31, 2025

(Amounts and Shares in Thousands)

(Unaudited)

	*For the Three Months Ended March 31, 2025*
						*Additional*				*Total*
	*Common Stock*					*Paid-in*		*Retained*		*Stockholders'*
	*Shares*			*Amount*		*Capital*		*Earnings*		*Equity*
Balance at January 1, 2025		18,148		$	18	$	594,044	$	376,430	$	970,492
Issuance of shares of common stock under restricted stock award agreements		227			—		—		—		—
Forfeiture of shares of common stock under restricted stock award agreements		(1	)		—		—		—		—
Stock-based compensation		—			—		3,170		—		3,170
Shares issued for exercise of stock options		25			—		493		—		493
Net income		—			—		—		21,228		21,228
Balance at March 31, 2025		18,399		$	18	$	597,707	$	397,658	$	995,383

Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Three Months Ended March 31, 2026 and 2025

(Amounts in Thousands)

(Unaudited)

	*For the Three Months Ended*
	*March 31,*
	*2026*			*2025*
Cash flows from operating activities:
Net income	$	25,069		$	21,228
Adjustments to reconcile net income to net cash provided by (used in) operating activities, net of acquisitions:
Depreciation and amortization		4,030			3,943
Deferred income taxes		140			166
Stock-based compensation		5,000			3,170
Amortization of debt issuance costs under the credit facility		328			318
Provision for credit losses		367			335
Gain on disposal of assets		(16	)		(7	)
(Gain) loss on termination of operating leases		(1	)		23
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable		6,567			(9,459	)
Prepaid expenses and other current assets		11,150			8,323
Government stimulus advances		2,938			(2,537	)
Accounts payable		(3,074	)		(588	)
Accrued payroll		(2,015	)		(7,124	)
Accrued expenses and other long-term liabilities		1,882			1,158
Net cash provided by operating activities		52,365			18,949
Cash flows from investing activities:
Acquisitions of businesses, net of cash acquired		—			(3,350	)
Purchases of property and equipment		(1,711	)		(1,883	)
Proceeds received from disposal of assets		19			7
Proceeds received from divestiture of business		—			3,848
Net cash used in investing activities		(1,692	)		(1,378	)
Cash flows from financing activities:
Payments on revolver — credit facility		(30,000	)		(20,000	)
Payments for debt issuance costs under the credit facility		(13	)		(21	)
Cash received from exercise of stock options		788			493
Net cash used in financing activities		(29,225	)		(19,528	)
Net change in cash		21,448			(1,957	)
Cash, at beginning of period		81,617			98,911
Cash, at end of period	$	103,065		$	96,954
Supplemental disclosures of cash flow information:
Cash paid for interest	$	1,802		$	3,743
Cash paid (refunded) for income taxes		2			(11	)

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1. Nature of Operations, Consolidation, and Presentation of Financial Statements

Addus HomeCare Corporation (“Holdings”) and its subsidiaries (together with Holdings, the “Company”, “we”, “us”, or “our”) operate as a multi-state provider of three distinct but related business segments providing in-home services. In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill, or disabled. In its hospice segment, the Company provides physical, emotional, and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy. The Company’s payors include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals.

Basis of Presentation

The accompanying Unaudited Condensed Consolidated Financial Statements and related notes have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q. The accompanying balance sheet as of December 31, 2025 has been derived from the Company’s audited financial statements for the year ended December 31, 2025 previously filed with the SEC. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements and should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, 2025 included in our Annual Report on Form 10-K, as amended (“Annual Report on Form 10-K”), which includes information and disclosures not included herein.

In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.

Principles of Consolidation

These Unaudited Condensed Consolidated Financial Statements include the accounts of Addus HomeCare Corporation and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

2. Summary of Significant Accounting Policies

Estimates

The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. The Company’s critical accounting estimates include the following areas: revenue recognition, goodwill and intangibles and business combinations, and when required, the quantitative assessment of goodwill. Actual results could differ from those estimates.

Table of Contents

Computation of Weighted Average Shares

The following table sets forth the computation of basic and diluted common shares:

	*For the Three Months Ended March 31,*
	(Amounts in thousands)
	*2026*		*2025*
Weighted average number of shares outstanding for basic per share calculation		18,194		17,976
Effect of dilutive potential shares:
Stock options		149		223
Restricted stock awards		143		112
Adjusted weighted average shares for diluted per share calculation		18,486		18,311
Anti-dilutive shares:
Stock options		—		—
Restricted stock awards		122		—

Recently Adopted Accounting Pronouncements

In December 2023, the FASB issued ASU 2023-09, Improvement to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. The Company adopted ASU 2023-09 during the year ended December 31, 2025. Adoption of the standard did not have a material impact on the Company’s consolidated financial statements and expanded income tax disclosures.

In July 2025, the FASB issued ASU 2025-05, Measurement of Credit Losses for Accounts Receivable and Contract Assets, which replaces the incurred-loss model with a forward-looking current expected credit loss model that requires recognition of lifetime expected credit losses on financial assets measured at amortized cost and certain off-balance-sheet credit exposures (including trade accounts receivable and contract assets), using historical experience, current conditions, and reasonable and supportable forecasts. ASU 2025-05 is effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods, with early adoption permitted. The disclosure updates should be applied prospectively. The Company adopted ASU 2025-05 during the three months ended March 31, 2026. Adoption did not have a material impact on the Company’s consolidated financial statements.

Recently Issued Accounting Pronouncements

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which intends to provide investors more detailed disclosures around specific types of expenses. The new disclosures require certain details for expenses presented on the face of the Consolidated Statements of Operations as well as selling expenses to be presented in the notes to the financial statements. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The disclosure updates are required to be applied prospectively with the option for retrospective application. The Company is currently assessing the impact and timing of adopting the updated provisions.

In September 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. The new guidance intends to modernize the guidance related to internal-use software costs to reflect current software development methods. It requires entities to begin capitalizing software costs when management authorizes and commits to funding the software project, and it is probable the project will be completed and the software will be used for its intended purpose. ASU 2025-06 is effective for fiscal years beginning after December 15, 2027, and interim periods within those fiscal years, and may be adopted using a prospective, retrospective, or modified transition approach. Early adoption is permitted. The Company is currently evaluating the impact on its consolidated financial statements.

In December 2025, the FASB issued ASU 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities, which provides guidance on the recognition, measurement, and presentation of government grants. ASU 2025-10 is effective for fiscal years beginning after December 15, 2028, and interim periods within those fiscal years, and permits modified prospective, modified retrospective, or full retrospective adoption, with early adoption permitted. The Company has evaluated the guidance and does not expect adoption to have a material impact on its consolidated financial statements or related disclosures.

In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements, which clarifies certain interim reporting guidance. ASU 2025-11 is effective for fiscal years beginning after December 15, 2027, and interim periods within those fiscal years. The Company has evaluated the guidance and does not expect adoption to have a material impact on its consolidated financial statements.

3. Divestiture

Effective May 20, 2024, the Company entered into a definitive asset purchase agreement to sell all of the Company’s New York operations for a purchase price of up to $23.0 million in cash, subject to certain adjustments, including adjustments for future operating requirements (the “New York Asset Sale”). The purchase price included 50% cash consideration, paid out as an initial payment of $4.6 million and $6.9 million paid pro rata as a deferred payment as caregivers are transferred, and 50% in the form of contingent consideration for the Company’s New York Consumer Directed Personal Assistance Program (“CDPAP”) business. No amount was recorded related to the CDPAP business contingent consideration. The Company entered into a consulting agreement with the purchaser effective May 20, 2024, as the transfer of clients and caregivers and payment for assets pursuant to the New York Asset Sale is occurring over time as regulatory approvals are received, coordination of the transfer of clients and caregivers occurs, and the change of control takes place. The Company determined that the consulting agreement gave it the ability to control the business until October 2024, when the Company determined that it no longer controlled the business as it transferred more than 50% of the clients and caregivers and therefore qualified for sale consideration of the New York Asset Sale. As a result, the Company deconsolidated the results of its New York operations and recorded a gain on divestiture of $3.7 million during the year ended December 31, 2024. The gain was reflected within general and administrative expenses on the consolidated statement of operations. During the three months ended March 31, 2026, the Company recorded a lease modification reducing operating lease assets and liabilities by $1.6 million.

4. Leases

Amounts reported on the Company’s Unaudited Condensed Consolidated Balance Sheets for operating leases were as follows:

	*March 31, 2026*		*December 31, 2025*
	(Amounts in Thousands)
Operating lease assets, net	$	40,999	$	43,713

Short-term operating lease liabilities		13,139		13,144
Long-term operating lease liabilities		34,331		37,259
Total operating lease liabilities	$	47,470	$	50,403

Lease Costs

Components of lease costs were reported in general and administrative expenses in the Company’s Unaudited Condensed Consolidated Statements of Income as follows:

	*For the Three Months Ended March 31,*
	(Amounts in Thousands)
	*2026*		*2025*
Operating lease costs	$	3,657	$	3,657
Short-term lease costs		254		284
Total lease costs		3,911		3,941
Less: sublease income		—		(226	)
Total lease costs, net	$	3,911	$	3,715

Lease Term and Discount Rate

Weighted average remaining lease terms and discount rates were as follows:

	*March 31, 2026*			*December 31, 2025*
Operating leases:
Weighted average remaining lease term		4.87			5.05
Weighted average discount rate		6.45	%		6.37	%

Maturity of Lease Liabilities

Remaining operating lease payments as of March 31, 2026 were as follows:

	*Operating Leases*
	(Amounts in Thousands)
Due in the 12-month period ended March 31,
2027	$	15,636
2028		11,968
2029		8,337
2030		6,152
2031		5,284
Thereafter		8,502
Total future minimum rental commitments		55,879
Less: Imputed interest		(8,409	)
Total lease liabilities	$	47,470

Supplemental Cash Flows Information

	*For the Three Months Ended March 31,*
	(Amounts in Thousands)
	*2026*		*2025*
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	4,179	$	4,182

Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	2,295	$	979

5. Goodwill and Intangible Assets

A summary of the goodwill by segment and related adjustments is provided below:

	*Hospice*			*Personal Care*		*Home Health*			*Total*
	(Amounts in Thousands)
Goodwill as of December 31, 2025	$	432,866		$	468,981	$	94,849		$	996,696
Additions for acquisitions		—			—		—			—
Adjustments to previously recorded goodwill		(14	)		47		(49	)		(16	)
Goodwill as of March 31, 2026	$	432,852		$	469,028	$	94,800		$	996,680

The Company’s identifiable intangible assets consist of customer and referral relationships, trade names and trademarks, non-competition agreements, and state licenses. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from one to twenty years. Customer and referral relationships are amortized systematically over the periods of expected economic benefit, which range from three to fifteen years.

The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following:

		*March 31, 2026*							*December 31, 2025*
		(Amounts in Thousands)							(Amounts in Thousands)
	*Estimated Useful*	*Gross*		*Accumulated*			*Net*		*Gross*		*Accumulated*			*Net*
	*Life (years)*	*carrying value*		*amortization*			*carrying value*		*carrying value*		*amortization*			*carrying value*
Customer and referral relationships	3 - 15	$	34,026	$	(33,562	)	$	464	$	34,201	$	(33,656	)	$	545
Trade names and trademarks	1 - 20		58,859		(27,186	)		31,673		59,366		(26,535	)		32,831
Non-competition agreement	3 - 5		6,728		(6,691	)		37		6,728		(6,663	)		65
State Licenses	6 - 10		26,529		(4,845	)		21,684		26,529		(4,190	)		22,339
State Licenses	Indefinite		46,630		—			46,630		46,630		—			46,630
Total intangible assets		$	172,772	$	(72,284	)	$	100,488	$	173,454	$	(71,044	)	$	102,410

Amortization expense related to the intangible assets was $1.9 million and $2.0 million for the three months ended March 31, 2026 and 2025, respectively. The weighted average remaining useful lives of identifiable intangible assets as of March 31, 2026 was 8.92 years.

6. Details of Certain Balance Sheet Accounts

Prepaid expenses and other current assets consisted of the following:

	*March 31, 2026*		*December 31, 2025*
	(Amounts in Thousands)
Income tax receivable	$	3,301	$	10,520
Prepaid payroll		5,676		7,960
Prepaid workers' compensation and liability insurance		3,220		5,694
Prepaid licensing fees		5,711		4,167
Workers' compensation insurance receivable		441		474
Other ⁽¹⁾		6,639		7,364
Total prepaid expenses and other current assets	$	24,988	$	36,179

(1)

Included $2.3 million related to the New York Asset Sale deferred payments as of March 31, 2026 and December 31, 2025.

Accrued expenses consisted of the following:

	*March 31, 2026*		*December 31, 2025*
	(Amounts in Thousands)
Accrued health benefits	$	7,449	$	6,643
Accrued professional fees		6,553		6,390
Accrued payroll and other taxes		4,367		2,242
Other		11,979		12,916
Total accrued expenses	$	30,348	$	28,191

7. ARPA Spending Plans

To mitigate the fiscal effects of the COVID-19 public health emergency, the American Rescue Plan Act of 2021 (“ARPA”) provided for a 10-percentage point increase in federal matching funds for Medicaid home and community-based services (“HCBS”) from April 1, 2021, through March 31, 2022, provided the states satisfied certain conditions. States must submit periodic HCBS spending plans to CMS regarding the federal and state funds tied to the increase in federal matching funds. Although states were generally permitted to use the associated state funds by March 31, 2025, CMS granted extensions to several states and some state spending plans continue through September 30, 2026.

HCBS spending plans for the additional matching funds vary by state, but common initiatives in which the Company participates include those aimed at strengthening the provider workforce (e.g., efforts to recruit, retain, and train direct service providers). The Company is required to properly and fully document the use of such funds in reports to the state in which the funds originated. Funds may be subject to recoupment if not expended or if they are expended on non-approved uses.

During the three months ended March 31, 2026, the Company received additional state funding provided by the ARPA of $6.2 million. Of the total state funding received by the Company pursuant to the ARPA through March 31, 2026, the Company utilized $3.2 million during the three months ended March 31, 2026, primarily for caregivers and adding support to recruiting and retention efforts, included as a reduction of cost of service revenues in the Company’s Unaudited Condensed Consolidated Statements of Income. As of March 31, 2026, the deferred portion of ARPA funding of $14.6 million is included within Government stimulus advances on the Company’s Unaudited Condensed Consolidated Balance Sheets.

8. Long-Term Debt

Long-term debt consisted of the following:

	*March 31, 2026*			*December 31, 2025*
	(Amounts in Thousands)
Revolving loan under the credit facility	$	94,335		$	124,335
Less unamortized issuance costs		(3,061	)		(3,376	)
Long-term debt	$	91,274		$	120,959

Amended and Restated Senior Secured Credit Facility

On October 31, 2018, the Company entered into the Amended and Restated Credit Agreement, with certain lenders and Capital One, National Association, as a lender and as agent for all lenders, as amended by the First Amendment to Amended and Restated Credit Agreement, dated as of September 12, 2019, as further amended by the Second Amendment to Amended and Restated Credit Agreement, dated as of July 30, 2021, as further amended by the Third Amendment to Amended and Restated Credit Agreement, dated as of April 26, 2023, and as further amended by the Fourth Amendment to Amended and Restated Credit Agreement, dated as of October 22, 2024 (as described below, the “Fourth Amendment”) (as amended, the “Credit Agreement”, as used throughout this Quarterly Report on Form 10-Q, “credit facility” shall mean the credit facility evidenced by the Credit Agreement). The credit facility consists of a $650.0 million revolving credit facility and a $150.0 million incremental loan facility, which incremental loan facility may be for term loans or an increase to the revolving loan commitments. The maturity of this credit facility is July 30, 2028.

On October 22, 2024, the Company entered into the Fourth Amendment to, among other things, (a) increase the Company’s revolving credit facility to an aggregate amount of $650.0 million, (b) increase the Company’s incremental loan facility to an aggregate amount of $150.0 million, and (c) extend the maturity date of the credit facility from July 30, 2026 to July 30, 2028.

Interest on the credit facility may be payable at (x) the sum of (i) an applicable margin ranging from 0.75% to 1.50% based on the applicable senior net leverage ratio plus (ii) a base rate equal to the greatest of (a) the rate of interest last quoted by The Wall Street Journal as the “prime rate,” (b) the sum of the federal funds rate plus a margin of 0.50%, and (c) the sum of Term Secured Overnight Financing Rate (“SOFR”) (as published by the CME Group Benchmark Administrative Limited) for an interest period of one month for such applicable day (not to be less than 0.00%), plus a margin of 1.00% or (y) the sum of (i) an applicable margin ranging from 1.75% to 2.50% based on the applicable senior net leverage ratio plus (ii) the rate per annum equal to the sum of Term SOFR (as published by the CME Group Benchmark Administrative Limited) for the applicable interest period (not to be less than 0.00%). Swing loans may not be SOFR loans.

Addus HealthCare, Inc. (“Addus HealthCare”) is the borrower, and its parent, Holdings, and substantially all of Holdings’ subsidiaries are guarantors under this credit facility, and it is collateralized by a first priority security interest in all of the Company’s and the other credit parties’ current and future tangible and intangible assets, including the shares of stock of the borrower and subsidiaries. The Credit Agreement contains affirmative and negative covenants customary for credit facilities of this type, including limitations on the Company with respect to liens, indebtedness, guaranties, investments, distributions, mergers and acquisitions, and dispositions of assets. The availability of additional draws under this credit facility is conditioned, among other things, upon (after giving effect to such draws) the Total Net Leverage Ratio (as defined in the Credit Agreement) not exceeding 3.75:1.00. In certain circumstances, in connection with a Material Acquisition (as defined in the Credit Agreement), the Company can elect to increase its Total Net Leverage Ratio compliance covenant to 4.25:1.00 for the then current fiscal quarter and the three succeeding fiscal quarters.

The Company pays a fee ranging from 0.20% to 0.35% based on the applicable senior net leverage ratio times the unused portion of the revolving loan portion of the credit facility.

The Credit Agreement contains customary affirmative covenants regarding, among other things, the maintenance of records, compliance with laws, maintenance of permits, maintenance of insurance and property and payment of taxes. The Credit Agreement also contains certain customary financial covenants and negative covenants that, among other things, include a requirement to maintain a minimum Interest Coverage Ratio (as defined in the Credit Agreement) and a requirement to stay below a maximum Total Net Leverage Ratio (as defined in the Credit Agreement). The Credit Agreement also contains restrictions on guarantees, indebtedness, liens, investments and loans, subject to customary carve outs, a restriction on dividends (provided that Addus HealthCare may make distributions to the Company in an amount that does not exceed $10.0 million in any year absent of an event of default, plus limited exceptions for tax and administrative distributions), a restriction on the ability to consummate acquisitions (without the consent of the lenders) under its credit facility subject to compliance with the Total Net Leverage Ratio (as defined in the Credit Agreement) thresholds, restrictions on mergers, dispositions of assets, and affiliate transactions, and restrictions on fundamental changes and lines of business.

During the three months ended March 31, 2026, the Company did not draw on its credit facility and repaid $30.0 million under the revolving credit facility.

As of March 31, 2026, the Company had a total of $94.3 million of revolving loans, with an interest rate of 5.43%, outstanding on its credit facility. After giving effect to the amount drawn on its credit facility, approximately $7.9 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), the Company had $650.0 million of capacity and $547.8 million available for borrowing under its credit facility. As of December 31, 2025, the Company had a total of $124.3 million of revolving loans, with an interest rate of 5.48%, outstanding on its credit facility.

As of March 31, 2026, the Company was in compliance with all financial covenants under the Credit Agreement.

9. Income Taxes

The effective income tax rates were 22.7% and 21.4% for the three months ended March 31, 2026 and 2025, respectively.

For the three months ended March 31, 2026, the difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes, non-deductible compensation, partially offset by the use of federal employment tax credits and an excess tax benefit. For both the three months ended March 31, 2026 and 2025, the effective tax rates were inclusive of an excess tax benefit of 3.1% and 4.7%, respectively. The excess tax expense and tax benefit are discrete items, related to the vesting of equity shares, which requires the Company to recognize the expense or benefit fully in the period. An excess tax expense results if the Company’s cumulative costs of the award recognized exceed the income tax deduction, whereas an excess tax benefit results if the Company’s cumulative costs of the award recognized are less than the income tax deduction.

10. Commitments and Contingencies

Legal Proceedings

From time to time, the Company is subject to legal and/or administrative proceedings incidental to its business.

It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on the Company’s Unaudited Condensed Consolidated Balance Sheets and Unaudited Condensed Consolidated Statements of Income.

11. Segment Information

Operating segments are defined as components of a company that engage in business activities from which it may earn revenues and incur expenses, and for which separate financial information is available and is regularly reviewed by the Company’s CODM. The Company identifies its Chief Executive Officer and Chief Operating Officer together as CODMs to assess the performance of the individual segments and make decisions about resources to be allocated to the segments. The Company operates as a multi-state provider of three business segments providing in-home services.

In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional, and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy.

The Company’s method for measuring profitability on each reportable segment basis is the same as those described in the summary of significant accounting policies and its CODMs frequently review the actual result to budget variance to allocate resources to the segment and assess its performance. Segment operating income consists of revenue generated by a segment, less the direct costs of service revenues and general and administrative expenses that are incurred directly by the segment. Unallocated general and administrative costs are those costs for functions performed in a centralized manner and therefore not attributable to a particular segment. These costs include accounting, finance, human resources, legal, information technology, corporate office support and facility costs and overall corporate management.

The CODMs do not review disaggregated assets by segment. The measure of segment assets is reported on the balance sheet as total consolidated assets.

Table of Contents

The tables below set forth information about the Company’s reportable segments, along with the items necessary to reconcile the segment information to the totals reported in the accompanying Unaudited Condensed Consolidated Financial Statements.

	*For the Three Months Ended March 31, 2026*
	(Amounts in Thousands)
	*Personal Care*		*Hospice*		*Home Health*		*Total*
Net service revenues	$	281,094	$	65,785	$	16,732	$	363,611
Direct service personnel		202,872		29,168		8,834		240,874
General and administrative salaries, wages and benefits		19,298		12,162		3,598		35,058
Other segment items ¹		6,058		9,803		1,137		16,998
Segment operating income		52,866		14,652		3,163		70,681
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								32,579
Depreciation and amortization								4,030
Interest income								(510	)
Interest expense								2,151
Income before income taxes							$	32,431

(1)

Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense.

	*For the Three Months Ended March 31, 2025*
	(Amounts in Thousands)
	*Personal Care*		*Hospice*		*Home Health*		*Total*
Net service revenues	$	258,286	$	61,437	$	17,985	$	337,708
Direct service personnel		186,650		26,205		10,413		223,268
General and administrative salaries, wages and benefits		18,239		10,980		3,279		32,498
Other segment items ¹		5,805		9,635		1,279		16,719
Segment operating income		47,592		14,617		3,014		65,223
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								30,766
Depreciation and amortization								3,943
Interest income								(502	)
Interest expense								4,018
Income before income taxes							$	26,998

(1)

Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense.

Table of Contents

12. Significant Payors

The Company’s revenue by payor type was as follows:

*Personal Care Segment*	*For the Three Months Ended March 31,*
	*2026*					*2025*
			*% of Segment*					*% of Segment*
	*Amount*		*Net Service*			*Amount*		*Net Service*
	*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*
State, local and other governmental programs	$	139,641		49.7	%	$	132,904		51.5	%
Managed care organizations		133,669		47.6			117,007		45.3
Private pay		6,227		2.2			6,976		2.7
Commercial insurance		1,106		0.4			1,160		0.4
Other		451		0.1			239		0.1
Total personal care segment net service revenues	$	281,094		100.0	%	$	258,286		100.0	%

*Hospice Segment*	*For the Three Months Ended March 31,*
	*2026*					*2025*
			*% of Segment*					*% of Segment*
	*Amount*		*Net Service*			*Amount*		*Net Service*
	*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*
Medicare	$	62,101		94.4	%	$	56,788		92.4	%
Commercial insurance		1,810		2.8			2,383		3.9
Managed care organizations		1,492		2.3			2,028		3.3
Other		382		0.5			238		0.4
Total hospice segment net service revenues	$	65,785		100.0	%	$	61,437		100.0	%

*Home Health Segment*	*For the Three Months Ended March 31,*
	*2026*					*2025*
			*% of Segment*					*% of Segment*
	*Amount*		*Net Service*			*Amount*		*Net Service*
	*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*
Medicare	$	10,227		61.1	%	$	12,576		69.9	%
Managed care organizations		3,970		23.7			3,810		21.2
State, local and other governmental programs (excluding Medicare)		2,046		12.2			1,087		6.0
Other		489		3.0			512		2.9
Total home health segment net service revenues	$	16,732		100.0	%	$	17,985		100.0	%

The Company derives a significant amount of its revenue from its operations in Illinois, New Mexico, Ohio, Tennessee, and Texas. The percentages of segment revenue for each of these significant states and New York for the three months ended March 31, 2026 and 2025, respectively, were as follows:

*Personal Care Segment*	*For the Three Months Ended March 31,*
	*2026*					*2025*
			*% of Segment*					*% of Segment*
	*Amount*		*Net Service*			*Amount*		*Net Service*
	*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*
Illinois	$	116,750		41.5	%	$	111,414		43.1	%
Texas		57,390		20.4			49,861		19.3
New Mexico		30,490		10.8			28,305		11.0
New York(1)		—		—			273		0.1
All other states		76,464		27.3			68,433		26.5
Total personal care segment net service revenues	$	281,094		100.0	%	$	258,286		100.0	%

(1)

As a result of changes and uncertainty in New York regarding the CDPAP, the Company determined that its New York personal care operations no longer fit its growth strategy and is divesting these operations. See Note 3 to the Notes to Unaudited Condensed Consolidated Financial Statements, Divestiture, for additional details regarding our divestiture.

*Hospice Segment*	*For the Three Months Ended March 31,*
	*2026*					*2025*
			*% of Segment*					*% of Segment*
	*Amount*		*Net Service*			*Amount*		*Net Service*
	*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*
Ohio	$	26,466		40.2	%	$	23,187		37.7	%
Illinois		14,339		21.8			14,564		23.7
New Mexico		7,871		12.0			7,913		12.9
All other states		17,109		26.0			15,773		25.7
Total hospice segment net service revenues	$	65,785		100.0	%	$	61,437		100.0	%

*Home Health Segment*	*For the Three Months Ended March 31,*
	*2026*					*2025*
			*% of Segment*					*% of Segment*
	*Amount*		*Net Service*			*Amount*		*Net Service*
	*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*
New Mexico	$	8,539		51.0	%	$	8,555		47.6	%
Tennessee		6,884		41.1			7,498		41.7
Illinois		1,309		7.9			1,932		10.7
Total home health segment net service revenues	$	16,732		100.0	%	$	17,985		100.0	%

A substantial portion of the Company’s revenue and accounts receivable are derived from services performed for federal, state, and local governmental agencies. The personal care segment derives a significant amount of its net service revenues in Illinois, which represented 32.1% and 33.0% of our net service revenues for the three months ended March 31, 2026 and 2025, respectively. The Illinois Department on Aging, the largest payor program for the Company’s Illinois personal care operations, accounted for 17.8% and 18.5% of the Company’s net service revenues for the three months ended March 31, 2026 and 2025, respectively.

The related receivables due from the Illinois Department on Aging represented 23.1% and 25.2% of the Company’s net accounts receivable at March 31, 2026 and December 31, 2025, respectively.

13. Subsequent Events

On May 1, 2026, the Company completed the acquisition of substantially all of the assets of an Indiana limited liability company doing business as HomeCourt Home Care for approximately $12.5 million (the “HomeCourt Acquisition”). The purchase was funded through the Company’s available cash. The HomeCourt Acquisition expanded the Company’s services within its personal care segment in Indiana. The initial accounting is not yet complete, and therefore the related business combination disclosures have not been presented as the Company is currently in the process of valuing the assets acquired and liabilities assumed in the transaction.

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion together with our unaudited condensed consolidated financial statements and the related notes included elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements about our business and operations. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words like “believes,” “belief,” “expects,” “plans,” “anticipates,” “intends,” “projects,” “estimates,” “may,” “might,” “would,” “should,” and similar expressions are intended to be forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and assumptions of our management based on information currently available to management. Such forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the impact of macroeconomic conditions, including inflation and interest rates, legislative and political developments, including federal government shutdowns, any lapse in appropriations and any hold on or cancellation of congressionally authorized spending or interruptions in the distribution of government funds, trade policies and tensions, including changes in, or the imposition of, tariffs and/or trade barriers and the economic impacts, volatility and uncertainty resulting therefrom, and the potential adverse effects of current conditions; business disruptions due to inclement weather, natural disasters, acts of terrorism, military conflicts, pandemics, civil insurrection or social unrest; changes in operational and reimbursement processes and payment structures at the state or federal levels; changes in Medicaid, Medicare, other government program and managed care organizations’ policies and payment rates, and the timeliness of reimbursements received under government programs; the implementation of new, and possible changes to existing, federal and state laws or regulations, or our failure to comply with such laws or regulations or comply on a timely basis; the impact of decisions of the U.S. Supreme Court regarding the actions of federal agencies; changes in the executive branch of the federal government; changes in the structure and administration of, and funding for, federal and state agencies and programs; competition in the healthcare industry; the geographical concentration of our operations; changes in the case mix of consumers and payment methodologies; operational changes resulting from the assumption by managed care organizations of responsibility for managing and paying for our services to consumers; the nature and success of future financial and/or delivery system reforms; changes in estimates and judgments associated with critical accounting policies; our ability to maintain or establish new referral sources; our ability to renew significant agreements or groups of agreements; our ability to attract and retain qualified personnel; federal, state and city minimum wage pressure, including any failure of any governmental entity to enact a minimum wage offset and/or the timing of any such enactment; changes in payments and covered services due to overall economic conditions and deficit or spending reduction measures by federal and state governments, and our expectations regarding these changes; cost containment initiatives undertaken by federal and state governmental and other third-party payors; our ability to access financing through the capital and credit markets; our ability to meet debt service requirements and comply with covenants in debt agreements; our ability to integrate and manage our information systems; any security breaches, cyber-attacks, loss of data, or cybersecurity threats or incidents, and any actual or perceived failures to comply with legal requirements related to the privacy of confidential consumer data and other sensitive information; the size and growth of the markets for our services, including our expectations regarding the markets for our services; eligibility standards and limits on services imposed through legislation or by governmental agencies or other third-party payors; the potential for litigation, audits, and investigations; discretionary determinations by government officials; our ability to successfully implement our business model to grow our business; our ability to continue identifying, pursuing, consummating, and integrating acquisition opportunities and expanding into new geographic markets; the impact of acquisitions and dispositions on our business, including the potential inability to realize the benefits of potential acquisitions; the effectiveness, quality, and cost of our services; our ability to successfully execute our growth strategy; changes in tax rates; and various other matters, many of which are beyond our control. In addition, these forward-looking statements are subject to the risk factors set forth in Part I, Item 1A of our Annual Report on Form 10-K for the period ended December 31, 2025, filed with the SEC. You should carefully review all of these factors. Moreover, our business may be materially adversely affected by factors that are not currently known to us, by factors that we currently consider immaterial or by factors that are not specific to us, such as general economic conditions. These forward-looking statements were based on information, plans, and estimates at the date of this report, and we assume no obligation to update any forward-looking statements to reflect changes in underlying assumptions or factors, new information, future events or other changes, except as may be required by law.

Table of Contents

Overview

We are a home care services provider operating three segments: personal care, hospice, and home health. Our services are principally provided in-home under agreements with federal, state, and local government agencies, managed care organizations, commercial insurers, and private individuals. Our consumers are predominantly “dual eligible,” meaning they are eligible to receive both Medicare and Medicaid benefits. Managed care organizations accounted for 38.3% and 36.4% of our net service revenues during the three months ended March 31, 2026 and 2025, respectively.

A summary of certain consolidated financial results is provided in the table below.

	For the Three Months Ended March 31,
	2026		2025
Net service revenues by segment:	(Amounts in Thousands)
Personal care	$	281,094	$	258,286
Hospice		65,785		61,437
Home health		16,732		17,985
Total net service revenue	$	363,611	$	337,708

Net income	$	25,069	$	21,228

As of March 31, 2026, we provided our services in 23 states through 263 offices. Our personal care segment also includes staffing services, with clients including assisted living facilities, nursing homes, and hospice facilities.

Acquisitions

In addition to our organic growth, we have grown through acquisitions that have expanded our presence in current markets, with the goal of having all three levels of in-home care in our markets or facilitating our entry into new markets where in-home care has been moving to managed care organizations or that present other strategic opportunities.

On January 1, 2025, the Company completed its acquisition of its Jacksonville affiliate (the “Jacksonville Acquisition”) for approximately $0.8 million, with funding provided by available cash. With the Jacksonville Acquisition, the Company expanded its personal care segment in Florida and recorded goodwill of $0.8 million.

On March 1, 2025, the Company completed its acquisition of the assets of Great Lakes Home Care Unlimited, LLC (the “Great Lakes Acquisition”) for $2.6 million, with funding provided by available cash. With the Great Lakes Acquisition, the Company expanded its personal care segment in Michigan and recognized goodwill in its personal care segment of $2.6 million.

On August 1, 2025, the Company completed its acquisition of Helping Hands Home Care Service, Inc. (the “Helping Hands Acquisition”), for approximately $21.4 million, with funding through the Company’s revolving credit facility and available cash. With the purchase of Helping Hands, the Company expanded its services within its personal care segment and entered the hospice and home health markets in Pennsylvania and recognized goodwill in its personal care segment of $19.0 million.

On October 1, 2025, the Company completed its acquisition of Gold Horses, LLC (the “Gold Horses Acquisition”), for approximately $7.4 million, with funding provided by available cash. With the Gold Horses Acquisition, the Company expanded its services within its personal care segment in Texas and recognized goodwill in its personal care segment of $7.4 million.

New York Asset Sale

Effective May 20, 2024, we entered into the New York Asset Sale. The Company entered into a consulting agreement with the purchaser, as the transfer of clients and caregivers and payment for assets pursuant to the New York Asset Sale is occurring over time as regulatory approvals are received, coordination of the transfer of clients and caregivers occurs, and the change of control takes place. In connection with this transaction, the Company ceased operations in New York. See Note 3 to the Notes to Unaudited Condensed Consolidated Financial Statements, Divestiture, for additional details regarding our divestiture.

Recruiting

As the labor market continues to be tight and unemployment remains at low levels, the competition for new caregivers, including skilled healthcare staff, and support staff continues to be significant. In addition, the United States economy continues to experience inflationary pressures. To the extent that we continue to experience a shortage of caregivers, it may hinder our ability to fully meet the continuing demand for both our non-clinical and clinical services.

Revenue by Payor and Significant States

Our payors are principally federal, state, and local governmental agencies and managed care organizations. The federal, state, and local programs under which the agencies operate are subject to legislative and budgetary changes and other risks that can influence reimbursement rates. We have experienced a transition of business from government payors to managed care organizations, which we believe aligns with our emphasis on coordinated care and the reduction of the need for acute care.

Our revenue by payor and significant states by segment were as follows:

*Personal Care Segment*	For the Three Months Ended March 31,
	2026					2025
			% of Segment					% of Segment
	Amount		Net Service			Amount		Net Service
	(in Thousands)		Revenues			(in Thousands)		Revenues
State, local and other governmental programs	$	139,641		49.7	%	$	132,904		51.5	%
Managed care organizations		133,669		47.6			117,007		45.3
Private pay		6,227		2.2			6,976		2.7
Commercial insurance		1,106		0.4			1,160		0.4
Other		451		0.1			239		0.1
Total personal care segment net service revenues	$	281,094		100.0	%	$	258,286		100.0	%
Illinois		116,750		41.5	%		111,414		43.1	%
Texas		57,390		20.4			49,861		19.3
New Mexico		30,490		10.8			28,305		11.0
New York		—		—			273		0.1
All other states		76,464		27.3			68,433		26.5
Total personal care segment net service revenues	$	281,094		100.0	%	$	258,286		100.0	%

*Hospice Segment*	For the Three Months Ended March 31,
	2026					2025
			% of Segment					% of Segment
	Amount		Net Service			Amount		Net Service
	(in Thousands)		Revenues			(in Thousands)		Revenues
Medicare	$	62,101		94.4	%	$	56,788		92.4	%
Commercial insurance		1,810		2.8			2,383		3.9
Managed care organizations		1,492		2.3			2,028		3.3
Other		382		0.5			238		0.4
Total hospice segment net service revenues	$	65,785		100.0	%	$	61,437		100.0	%
Ohio	$	26,466		40.2	%	$	23,187		37.7	%
Illinois		14,339		21.8			14,564		23.7
New Mexico		7,871		12.0			7,913		12.9
All other states		17,109		26.0			15,773		25.7
Total hospice segment net service revenues	$	65,785		100.0	%	$	61,437		100.0	%

*Home Health Segment*	For the Three Months Ended March 31,
	2026					2025
			% of Segment					% of Segment
	Amount		Net Service			Amount		Net Service
	(in Thousands)		Revenues			(in Thousands)		Revenues
Medicare	$	10,227		61.1	%	$	12,576		69.9	%
Managed care organizations		3,970		23.7			3,810		21.2
State, local and other governmental programs (excluding Medicare)		2,046		12.2			1,087		6.0
Other		489		3.0			512		2.9
Total home health segment net service revenues	$	16,732		100.0	%	$	17,985		100.0	%
New Mexico	$	8,539		51.0	%	$	8,555		47.6	%
Tennessee		6,884		41.1			7,498		41.7
Illinois		1,309		7.9			1,932		10.7
Total home health segment net service revenues	$	16,732		100.0	%	$	17,985		100.0	%

The personal care segment derives a significant amount of its net service revenues in Illinois, which represented 32.1% and 33.0% of our net service revenues for the three months ended March 31, 2026 and 2025, respectively.

A significant amount of our net service revenues are derived from one payor, the Illinois Department on Aging, the largest payor program for our Illinois personal care operations, which accounted for 17.8% and 18.5% of our net service revenues for the three months ended March 31, 2026 and 2025, respectively.

Changes in Illinois Reimbursement

As noted above, we derive a significant amount of our net service revenues in Illinois. Changes to reimbursement rates and minimum wage requirements may materially impact our revenues. For example, the Illinois fiscal year 2026 budget included an increase in hourly rates for in-home care services to $30.80, effective January 1, 2026, and required a minimum wage of $18.75 per hour for direct service workers. CMS approved an amendment to Illinois’ Persons Who are Elderly waiver program that included this rate increase, effective January 1, 2026.

The City of Chicago requires the Chicago minimum wage to be adjusted annually based on increases in the Consumer Price Index (“CPI”), subject to a cap and other requirements. Effective July 1, 2025, the rate was adjusted to $16.60 based on the increase in the CPI.

Our business will benefit from the rate increases noted above for 2026, but there is no assurance that there will be additional rate increases in Illinois for fiscal years beyond fiscal year 2026 to offset increases to minimum wage, and our financial performance will be adversely impacted for any periods in which an additional offsetting reimbursement rate increase is not in effect.

Changes in Texas Reimbursement

The Texas fiscal year 2026 budget included an increase in hourly rates to $17.13 for in-home care services effective September 1, 2025.

Changes in Medicare Reimbursement

Hospice

Hospice services provided to Medicare beneficiaries are paid under the Medicare Hospice Prospective Payment System, under which CMS sets a daily rate for each day a patient is enrolled in the hospice benefit. The daily rate depends on the level of care provided to a patient (routine home care, continuous home care, inpatient respite care, or general inpatient care). Daily rates are adjusted for factors such as area wage levels. CMS updates hospice payment rates each federal fiscal year. Effective October 1, 2025, CMS increased hospice payment rates by 2.6%. This reflects a 3.3% market basket increase and a negative 0.7 percentage point productivity adjustment. Hospices that do not satisfy quality reporting requirements are subject to a 4-percentage point reduction to the market basket update.

Overall payments made by Medicare to each hospice provider number are subject to an inpatient cap and an aggregate cap. The inpatient cap limits the number of days of inpatient care for which Medicare will pay to no more than 20% of total patient care days. Days in excess of the limitation are paid at the routine home care rate. The aggregate cap limits the total Medicare reimbursement that a hospice may receive in a cap year (typically the federal fiscal year) based on an annual per-beneficiary cap amount, which is set each federal fiscal year, and the number of Medicare patients served. The per-beneficiary cap amount was updated to $35,361.44 for federal fiscal year 2026. If a hospice’s Medicare payments exceed its inpatient or aggregate caps, it must repay Medicare the excess amount.

Home Health

Home health services provided to Medicare beneficiaries are paid under the Medicare Home Health Prospective Payment System (“HHPPS”), which uses national, standardized 30-day period payment rates for periods of care that meet a certain threshold of home health visits (periods of care that do not meet the visit threshold are paid a per-visit payment rate for the discipline providing care). Although payment is made for each 30-day period, the HHPPS permits continuous 60-day certification periods through which beneficiaries are verified as eligible for the home health benefit. The daily home health payment rate is adjusted for case-mix and area wage levels. CMS uses the Patient-Driven Groupings Model (“PDGM”) as the case-mix classification model to place periods of care into payment categories, classifying patients based on clinical characteristics and their resource needs. An outlier adjustment may be paid for periods of care where costs exceed a specific threshold amount.

CMS updates the HHPPS payment rates each calendar year. For calendar year 2026, CMS estimates that Medicare payments to home health agencies will decrease by 1.3%. This is based on a home health payment update percentage of 2.4%, which reflects a 3.2% market basket update, reduced by a productivity adjustment of 0.8 percentage points, among other changes. Home health providers that do not comply with quality data reporting requirements are subject to a 2-percentage point reduction to their market basket update. In addition, Medicare requires home health agencies to submit a one-time Notice of Admission (“NOA”) for each patient that establishes that the beneficiary is under a Medicare home health period of care. Failure to submit the NOA within five calendar days from the start of care will result in a reduction to the 30-day period payment amount for each day from the start of care date until the date the NOA is submitted.

Under the nationwide Home Health Value-Based Purchasing (“HHVBP”) Model, home health agencies receive increases or decreases to their Medicare fee-for-service payments of up to 5% based on performance against specific quality measures relative to the performance of other home health providers. Data collected in each performance year will impact Medicare payments two years later.

Payment of claims may be impacted by the Review Choice Demonstration for Home Health Services, a program intended to identify and prevent fraud, reduce the number of Medicare appeals and improve provider compliance with Medicare program requirements. The program is currently limited to home health agencies in Illinois, Ohio, Oklahoma, North Carolina, Florida, and Texas. Providers in states subject to the Review Choice Demonstration for Home Health Services may initially select either pre-claim review or post-payment review. Home health agencies that maintain high compliance levels are eligible for additional options that may be less burdensome. This program has not had a material impact on our results of operations or financial position.

CMS Final Rule: “Ensuring Access to Medicaid Services”

In May 2024, CMS finalized a rule intended to improve access to services and quality of care for Medicaid beneficiaries across fee-for-service and managed care delivery systems. The final rule includes significant provisions related to HCBS, including the “80/20” or “payment adequacy” requirement, which will require states to ensure by mid-2030 that at least 80% of all Medicaid payments a provider receives for homemaker, home health aide, and personal care services, less certain excluded costs, under specified programs are spent on total compensation (including benefits) for direct care workers furnishing these services, rather than administrative overhead or profit, subject to limited exceptions. The final rule includes several other measures intended to promote transparency and enhance quality and access to services, including a variety of reporting requirements for states. Given the long implementation period and the likelihood of further changes as a result of litigation, administration and congressional changes, further rule-making and state changes in response to the final rule, it is premature to predict the ultimate impact of the final rule on our business. Some states have adopted or may consider adopting similar caregiver compensation requirements.

Table of Contents

Potential Developments

Home care and other healthcare providers may be significantly impacted by changes to the Medicaid program, including changes resulting from legislation and administrative actions at the federal and state levels. Federal actions may impact funding for, or the structure of, the Medicaid program, including through changes to Medicaid waiver programs, and may shape provider reimbursement rates, eligibility and coverage policies, waiver programs and other aspects of state Medicaid programs at the state level. For example, the budget reconciliation legislation enacted on July 4, 2025, commonly known as the “One Big Beautiful Bill Act” (“OBBBA”), includes provisions that are expected to result in Medicaid spending reductions and changes in administration of state Medicaid programs. Among other changes, the law requires changes to Medicaid financing mechanisms, including restrictions intended to reduce the federal matching funds received by state Medicaid programs, with greater restrictions in states that have expanded Medicaid. In addition, some members of Congress and the executive branch have raised, and Congress in the future may adopt, other proposals intended to reduce Medicaid expenditures such as restructuring the Medicaid program to give states a “block grant” or fixed amount of overall funding for their respective Medicaid programs or to impose spending caps such as per Medicaid beneficiary limits on federal contributions. Reductions in federal funding or changes to the federal funding formula for Medicaid under the OBBBA or future initiatives could have a significant impact, particularly in states that expanded Medicaid under the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (collectively, the “ACA”), and especially if federal contributions for Medicaid expansion populations decrease and states are unable to offset the reductions. Decreased federal funding and increased state obligations and administrative burden could strain state budgets, which could result in state limitations on Medicaid eligibility or coverage, payment rate reductions, and changes to Medicaid waiver programs, among other effects.

The outcome of the 2024 federal elections, affecting both the executive and legislative branches, has increased regulatory uncertainty and the potential for significant policy changes. The President has issued executive orders that impact or may impact the healthcare industry. Further, some members of Congress and the presidential administration have raised potential measures intended to accelerate the shift from traditional Medicare to Medicare Advantage or eliminating some or all of the consumer protections established by the ACA.

Components of our Statements of Income

Net Service Revenues

We generate net service revenues by providing our services directly to consumers and primarily on an hourly basis in our personal care segment, on a daily basis in our hospice segment, and on an episodic basis in our home health segment. We receive payment for providing such services from our private consumers and payors, including federal, state, and local governmental agencies, managed care organizations, and commercial insurers.

In our personal care segment, net service revenues are principally provided based on authorized hours, determined by the relevant agency, at an hourly rate, which is either contractual or fixed by legislation, and are recognized at the time services are rendered. In our hospice segment, net service revenues are provided based on daily rates for each of the levels of care and are recognized as services are provided. In our home health segment, net service revenues are based on an episodic basis at a stated rate and recognized based on the number of days elapsed during a period of care within the reporting period. We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record revenues.

Cost of Service Revenues

We incur direct care wages, payroll taxes, and benefit-related costs in connection with providing our services. We also provide workers’ compensation and general liability coverage for our employees. Employees are also reimbursed for their travel time and related travel costs in certain instances.

General and Administrative Expenses

Our general and administrative expenses include our costs for operating our network of local agencies and our administrative offices. Our agency expenses consist of costs for supervisory personnel, our community care supervisors, and office administrative costs. Personnel costs include wages, payroll taxes, and employee benefits. Facility costs include rents, utilities, and postage, telephone, and office expenses. Our corporate and support center expenses include costs for accounting, information systems, human resources, billing and collections, contracting, marketing, and executive leadership. These expenses consist of compensation, including stock-based compensation, payroll taxes, employee benefits, legal, accounting and other professional fees, travel, general insurance, rents, provision for doubtful accounts, and related facility costs. Expenses related to streamlining our operations such as costs related to terminated employees, termination of professional services relationships, other contract termination costs, and asset write-offs are also included in general and administrative expenses.

Depreciation and Amortization Expenses

Depreciable assets consist principally of furniture and equipment, network administration and telephone equipment, and operating system software. Depreciable and leasehold assets are depreciated or amortized on a straight-line method over their useful lives or, if less and if applicable, their lease terms. We amortize our intangible assets with finite lives, consisting of customer and referral relationships, trade names, trademarks, and non-competition agreements, using straight line or accelerated methods based upon their estimated useful lives.

Interest Expense

Interest expense is reported when incurred and principally consists of interest and unused credit line fees on the credit facility.

Income Tax Expense

All of our income is from domestic sources. We incur state and local taxes in states in which we operate. The effective income tax rates were 22.7% and 21.4% for the three months ended March 31, 2026 and 2025, respectively, compared to our federal statutory rate of 21%. The difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes, non-deductible compensation, excess tax expense or benefit and the use of federal employment tax credits.

Results of Operations — Consolidated

Three Months Ended March 31, 2026 Compared to Three Months Ended March 31, 2025

The following table sets forth our unaudited condensed consolidated results of operations.

	For the Three Months Ended March 31,
	2026						2025						Change
				% Of						% Of
				Net Service						Net Service
	Amount			Revenues			Amount			Revenues			Amount			%
	(Amounts in Thousands, Except Percentages)
Net service revenues	$	363,611			100.0	%	$	337,708			100.0	%	$	25,903			7.7	%
Cost of service revenues		247,738			68.1			230,031			68.1			17,707			7.7
Gross profit		115,873			31.9			107,677			31.9			8,196			7.6
General and administrative expenses		77,771			21.4			73,220			21.7			4,551			6.2
Depreciation and amortization		4,030			1.1			3,943			1.2			87			2.2
Total operating expenses		81,801			22.5			77,163			22.9			4,638			6.0
Operating income		34,072			9.4			30,514			9.0			3,558			11.7
Interest income		(510	)		(0.1	)		(502	)		(0.1	)		(8	)		1.6
Interest expense		2,151			0.6			4,018			1.2			(1,867	)		(46.5	)
Total interest expense, net		1,641			0.5			3,516			1.1			(1,875	)		(53.3	)
Income before income taxes		32,431			8.9			26,998			8.0			5,433			20.1
Income tax expense		7,362			2.0			5,770			1.7			1,592			27.6
Net income	$	25,069			6.9	%	$	21,228			6.3	%	$	3,841			18.1	%

Net service revenues increased by 7.7% to $363.6 million for the three months ended March 31, 2026 compared to $337.7 million for the three months ended March 31, 2025. Revenue increased by $22.8 million in our personal care segment, by $4.3 million in our hospice segment and decreased by $1.3 million in our home health segment during the three months ended March 31, 2026, compared to the same period in 2025. The increase in our personal care segment was primarily due to organic growth in billable hours combined with the Gold Horses Acquisition and the Helping Hands Acquisition. The increase in our hospice segment revenue was due to organic growth in average daily census. The decrease in our home health segment was primarily attributed to lower volumes.

Gross profit, expressed as a percentage of net service revenues, was 31.9% for the three months ended March 31, 2026, compared to 31.9% for the same period in 2025.

General and administrative expenses increased to $77.8 million for the three months ended March 31, 2026, compared to $73.2 million for the three months ended March 31, 2025. The increase in general and administrative expenses was primarily due to acquisition activity, including the Gold Horses Acquisition and Helping Hands Acquisition, which contributed to an increase in administrative employee wage, bonus, tax, and benefit costs of $3.3 million. General and administrative expenses, expressed as a percentage of net service revenues, were 21.4% for the three months ended March 31, 2026, compared to 21.7% for the three months ended March 31, 2025.

Interest expense decreased to $2.2 million for the three months ended March 31, 2026 from $4.0 million for the three months ended March 31, 2025. The decrease in interest expense was primarily due to lower average outstanding borrowings and a lower weighted average interest rate under our credit facility for the three months ended March 31, 2026,compared to the three months ended March 31, 2025.

All of our income is from domestic sources. We incur state and local taxes in states in which we operate. The effective income tax rate was 22.7% and 21.4% for the three months ended March 31, 2026 and 2025, respectively. Our higher effective income tax rate for the three months ended March 31, 2026, was principally due to a lower excess tax benefit with a lower benefit from the use of federal employment tax credits. For the three months ended March 31, 2026 and 2025, the excess tax benefit and federal employment tax credits were 5.3% and 7.2%, respectively.

Results of Operations – Segments

The following tables and related analysis summarize our operating results and business metrics by segment:

Personal Care Segment

	For the Three Months Ended March 31,
	2026						2025						Change
				% of						% of
				Segment						Segment
				Net Service						Net Service
	Amount			Revenues			Amount			Revenues			Amount				%
	(Amounts in Thousands, Except Percentages)
Operating Results
Net service revenues	$	281,094			100.0	%	$	258,286			100.0	%	$	22,808		8.8	%
Cost of services revenues		203,273			72.3			186,964			72.4			16,309		8.7
Gross profit		77,821			27.7			71,322			27.6			6,499		9.1
General and administrative expenses		24,955			8.9			23,730			9.2			1,225		5.2
Segment operating income	$	52,866			18.8	%	$	47,592			18.4	%	$	5,274		11.1	%
Business Metrics (Actual Numbers, Except Billable Hours in Thousands)
Locations at period end		200						199
Average billable census * ⁽¹⁾		50,283						50,478						(195	)	(0.4	)%
Billable hours *⁽²⁾		10,733						10,201						532		5.2
Average billable hours per census per month * ⁽²⁾		71.1						67.4						3.7		5.5
Billable hours per business day * ⁽²⁾		167,699						159,395						8,304		5.2
Revenues per billable hour * ⁽²⁾	$	26.16					$	25.32					$	0.84		3.3	%
Same store growth revenue % * ⁽³⁾		6.5	%					7.4	%					(0.9	)	(12.2	)

(1)	Average billable census is the number of unique clients receiving a billable service during the year and is the total census divided by months in operation during the period.

(2)

Billable hours is the total number of hours served to clients during the period. Average billable hours per census per month is billable hours divided by average billable census. Billable hours per day is total billable hours divided by the number of business days in the period. Revenues per billable hour is revenue, attributed to billable bonus hours, divided by billable hours.

(3)

Same store growth reflects the change in year-over-year revenue for the same store base. We define the same store base to include those stores open for at least 52 full weeks. This measure highlights the performance of existing stores, while excluding the impact of acquisitions, new store openings and closures and ARPA associated revenue from this calculation.

* Management deems these metrics to be key performance indicators. Management uses these metrics to monitor our performance, both in our existing operations and acquisitions. Many of these metrics serve as the basis of reported revenues and assessment of these provide direct correlation to the results of operations from period to period and facilitate comparison with the results of our peers. Historical trends established in these metrics can be used to evaluate current operating results, identify trends affecting our business, determine the allocation of resources and assess the quality and potential variability of our cash flows and earnings. We believe they are useful to investors in evaluating and understanding our business but should not be used solely in assessing the Company’s performance. These key performance indicators should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented herein to fully evaluate and understand the business as a whole. These measures may not be comparable to similarly titled performance indicators used by other companies.

The personal care segment derives a significant amount of its net service revenues from operations in Illinois, which represented 32.1% and 33.0% of our net service revenues for the three months ended March 31, 2026 and 2025, respectively. One payor, the Illinois Department on Aging, accounted for 17.8% and 18.5% of net service revenues for the three months ended March 31, 2026 and 2025, respectively.

Net service revenues from state, local, and other governmental programs accounted for 49.7% and 51.5% of net service revenues for the three months ended March 31, 2026 and 2025, respectively. Managed care organizations accounted for 47.6% and 45.3% of net service revenues for the three months ended March 31, 2026 and 2025, respectively, with commercial insurance, private pay, and other payors accounting for the remainder of net service revenues.

Net service revenues increased by 8.8% for the three months ended March 31, 2026 compared to the three months ended March 31, 2025. Net service revenues included a 5.2% increase in billable hours and a 3.3% increase in revenues per billable hour for the three months ended March 31, 2026, compared to the three months ended March 31, 2025.

Gross profit, expressed as a percentage of net service revenues, was 27.7% for the three months ended March 31, 2026, compared to 27.6% for the three months ended March 31, 2025.

The personal care segment’s general and administrative expenses primarily consist of administrative employee wages, taxes, and benefit costs, rent, information technology, and office expenses. General and administrative expenses, expressed as a percentage of net service revenues, was 8.9% and 9.2% for the three months ended March 31, 2026 and 2025, respectively.

Table of Contents

Hospice Segment

	For the Three Months Ended March 31,
	2026						2025						Change
				% of						% of
				Segment						Segment
				Net Service						Net Service
	Amount			Revenues			Amount			Revenues			Amount				%
	(Amounts in Thousands, Except Percentages)
Operating Results
Net service revenues	$	65,785			100.0	%	$	61,437			100.0	%	$	4,348		7.1	%
Cost of services revenues		35,308			53.7			32,269			52.5			3,039		9.4
Gross profit		30,477			46.3			29,168			47.5			1,309		4.5
General and administrative expenses		15,825			24.1			14,551			23.7			1,274		8.8
Segment operating income	$	14,652			22.3	%	$	14,617			23.8	%	$	35		0.2	%
Business Metrics (Actual Numbers)
Locations at period end		40						38
Admissions * ⁽¹⁾		3,417						3,474						(57	)	(1.6	)%
Average daily census * ⁽²⁾		3,804						3,515						289		8.2
Average discharge length of stay * ⁽³⁾		110.6						97.4						13.2		13.5
Patient days * ⁽⁴⁾		342,359						316,319						26,040		8.2
Revenue per patient day *⁽⁵⁾	$	191.42					$	194.23					$	(2.81	)	(1.4	)
Organic growth
- Revenue * ⁽⁶⁾		7.7	%					9.9	%					(2.2	)	(22.2	)
- Average daily census * ⁽⁶⁾		7.9	%					4.6	%					3.3		71.7	%

(1)	Represents referral process and new patients on service during the period.

(2)	Average daily census is total patient days divided by the number of days in the period.

(3)	Average length of stay is the average number of days a patient is on service, calculated upon discharge, and is total patient days divided by total discharges in the period.

(4)	Patient days is days of service for all patients in the period.

(5)	Revenue per patient day is hospice revenue divided by the number of patient days in the period.

(6)

Revenue organic growth and average daily census organic growth reflect the change in year-over-year revenue and average daily census for the same store base. We define the same store base to include those stores open for at least 52 full weeks. These measures highlight the performance of existing stores, while excluding the impact of acquisitions, new store openings and closures.

The hospice segment generates revenue by providing care to patients with a life expectancy of six months or less, as well as related services for their families. Hospice offers four levels of care, as defined by Medicare, to meet the varying needs of patients and their families. The four levels of hospice include routine home care, continuous home care, general inpatient care and respite care. Our hospice segment principally provides routine home care.

Net service revenues from Medicare accounted for 94.4% and 92.4% for the three months ended March 31, 2026 and 2025, respectively. Net service revenues from managed care organizations accounted for 2.3% and 3.3% for the three months ended March 31, 2026 and 2025 respectively.

Net service revenues increased by $4.3 million for the three months ended March 31, 2026 compared to the three months ended March 31, 2025, primarily attributed to organic growth in average daily census, partially offset by a decrease in revenue per patient day.

Gross profit, expressed as a percentage of net service revenues, was 46.3% and 47.5% for the three months ended March 31, 2026 and 2025, respectively. For the three months ended March 31, 2026, the decrease was mainly attributed to an increase in direct wages, taxes and benefit costs as a percentage of net service revenues.

The hospice segment’s general and administrative expenses primarily consist of administrative employee wage, tax, and benefit costs, rent, information technology, and office expenses. General and administrative expenses, expressed as a percentage of net service revenues, was 24.1% and 23.7% for the three months ended March 31, 2026 and 2025, respectively.

Home Health Segment

	For the Three Months Ended March 31,
	2026						2025						Change
				% of						% of
				Segment						Segment
				Net Service						Net Service
	Amount			Revenues			Amount			Revenues			Amount				%
	(Amounts in Thousands, Except Percentages)
Operating Results
Net service revenues	$	16,732			100.0	%	$	17,985			100.0	%	$	(1,253	)	(7.0	)%
Cost of services revenues		9,156			54.7			10,798			60.0			(1,642	)	(15.2	)
Gross profit		7,576			45.3			7,187			40.0			389		5.4
General and administrative expenses		4,413			26.4			4,173			23.2			240		5.8
Segment operating income	$	3,163			18.9	%	$	3,014			16.8	%	$	149		4.9	%
Business Metrics (Actual Numbers)
Locations at period end		22						23
New admissions *⁽¹⁾		4,694						4,708						(14	)	(0.3	)%
Recertifications * ⁽²⁾		2,523						2,982						(459	)	(15.4	)
Total volume * ⁽³⁾		7,217						7,690						(473.0	)	(6.2	)
Visits * ⁽⁴⁾		80,892						94,593						(13,701	)	(14.5	)
Organic growth
- Revenue * ⁽⁵⁾		(6.6	)%					1.3	%					(7.9	)	(607.7	)
- Admissions * ⁽⁵⁾		(0.3	)%					(3.7	)%					3.4		(91.9	)%

(1)	Represents new patients during the period.

(2)

A home health certification period is an episode of care that begins with a start of care visit and continues for 60 days. If at the end of the initial episode of care, the patient continues to require home health services, a recertification is required. This represents the number of recertifications during the period.

(3)	Total volume is total admissions and total recertifications in the period.

(4)	Represents number of services to patients in the period.

(5)

Revenue organic growth and admissions organic growth reflect the change in year-over-year revenue and admissions for the same store base. We define the same store base to include those stores open for at least 52 full weeks. These measures highlight the performance of existing stores, while excluding the impact of acquisitions, new store openings, and closures.

The home health segment generates net service revenues by providing home health services on a short-term, intermittent or episodic basis to individuals, generally to treat an illness or injury. Net service revenues from Medicare accounted for 61.1% and 69.9%, managed care organizations accounted for 23.7% and 21.2%, and state, local, and other governmental programs accounted for 12.2% and 6.0% for the three months ended March 31, 2026 and 2025, respectively. Home health services provided to Medicare beneficiaries are paid under the Medicare Home Health Prospective Payment System, which uses national, standardized 30-day period payment rates for periods of care. CMS uses the PDGM as the case-mix classification model to place periods of care into payment categories, classifying patients based on clinical characteristics. An outlier adjustment may be paid for periods of care in which costs exceed a specific threshold amount.

Net service revenues decreased by $1.3 million for the three months ended March 31, 2026, compared to the three months ended March 31, 2025, primarily due to lower volumes, including lower recertifications and visits, and the continued impact of efforts to manage payor mix within our home health operations and related incremental margin improvements.

Gross profit, expressed as a percentage of net service revenues, was 45.3% and 40.0% for the three months ended March 31, 2026 and 2025, respectively. For the three months ended March 31, 2026, the increase was mainly attributed to a decrease in direct wages, taxes and benefit costs as a percentage of net service revenues, as cost of services revenues decreased at a greater rate than net service revenues, compared to the three months ended March 31, 2025.

The home health segment’s general and administrative expenses primarily consist of administrative employee wage, tax and benefit costs, rent, information technology, and office expenses. General and administrative expenses, expressed as a percentage of net service revenues, were 26.4% and 23.2% for the three months ended March 31, 2026 and 2025.

Liquidity and Capital Resources

Overview

Our primary sources of liquidity are cash on hand and cash from operations and borrowings under our credit facility. At March 31, 2026 and December 31, 2025, we had cash balances of $103.1 million and $81.6 million, respectively. At March 31, 2026, we had a $650.0 million revolving credit facility and a $150.0 million incremental loan facility, which may be for term loans or an increase to the revolving loan commitments. The maturity of this credit facility was extended to July 30, 2028.

During the three months ended March 31, 2026, we repaid $30.0 million under our revolving credit facility. As of March 31, 2026, we had a total of $94.3 million in revolving loans, with an interest rate of 5.43% outstanding on our credit facility and after giving effect to the amount drawn on our credit facility, approximately $7.9 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), we had $650.0 million of capacity and $547.8 million available for borrowing under our credit facility. At December 31, 2025, we had a total of $124.3 million revolving credit loans, with an interest rate of 5.48%, outstanding on our credit facility.

Our credit facility requires us to maintain a total net leverage ratio not exceeding 3.75:1.00. At March 31, 2026, we were in compliance with our financial covenants under the Credit Agreement. Although we believe our liquidity position remains strong, we can provide no assurance that we will remain in compliance with the covenants in our Credit Agreement, and in the future, it may prove necessary to seek an amendment with the bank lending group under our credit facility. Additionally, there can be no assurance that we will be able to raise additional funds on terms acceptable to us, if at all.

See Note 8 to the Notes to Unaudited Condensed Consolidated Financial Statements, Long-Term Debt, for additional details of our long-term debt.

Current Macroeconomic Conditions and American Rescue Plan Act of 2021 Relief Funding

Economic conditions in the United States continue to be challenging in various respects. For example, the United States economy continues to experience inflationary pressures, elevated interest rates, challenging labor market conditions and uncertainty regarding the impact of increased tariffs and trade disruptions. Any economic downturn would pose a risk to states’ revenues, which in turn could affect our reimbursements and collections received for services rendered. Depending on the severity and length of any potential economic downturn as well as the extent of any federal support, states could face significant fiscal challenges and revise their revenue forecasts and adjust their budgets, and sales tax collections and income tax withholdings could be depressed.

ARPA Spending Plans

To mitigate the fiscal effects of the COVID-19 public health emergency, the ARPA provided for a 10 percentage point increase in federal matching funds for Medicaid HCBS from April 1, 2021, through March 31, 2022, provided the state satisfied certain conditions. States must submit periodic HCBS spending plans to CMS regarding the federal and state funds tied to the increase in federal matching funds. Although states were generally permitted to use the associated state funds by March 31, 2025, CMS granted extensions to several states and some state spending plans continue through September 30, 2026.

HCBS spending plans for the additional matching funds vary by state, but common initiatives in which the Company is participating include those aimed at strengthening the provider workforce (e.g., efforts to recruit, retain, and train direct service providers). The Company is required to properly and fully document the use of such funds in reports to the state in which the funds originated. Funds may be subject to recoupment if not expended or if they are expended on non-approved uses.

During the three months ended March 31, 2026, the Company received additional state funding provided by the ARPA of $6.2 million. Of the total state funding received by the Company pursuant to the ARPA through March 31, 2026, the Company utilized $3.2 million during the three months ended March 31, 2026, primarily for caregivers and adding support to recruiting and retention efforts, included as a reduction of cost of service revenues in the Company’s Unaudited Condensed Consolidated Statements of Income. As of March 31, 2026, the deferred portion of ARPA funding of $14.6 million is included within Government stimulus advances on the Company’s Unaudited Condensed Consolidated Balance Sheets.

The following table summarizes changes in our cash flows:

	For the Three Months Ended March 31,
	2026			2025
	(Amounts in Thousands)
Net cash provided by operating activities	$	52,365		$	18,949
Net cash used in investing activities		(1,692	)		(1,378	)
Net cash used in financing activities		(29,225	)		(19,528	)

Three Months Ended March 31, 2026 Compared to Three Months Ended March 31, 2025

Cash flows from operating activities represent the inflow of cash from our payors and the outflow of cash for payroll and payroll taxes, operating expenses, interest, and taxes. Net cash provided by operating activities was $52.4 million for the three months ended March 31, 2026, compared to net cash provided by operating activities of $18.9 million for the same period in 2025. The increase in cash provided by operations was primarily due to the timing of receipts on accounts receivable and the timing of receipt and utilization of government stimulus funds. The changes in accounts receivable were primarily related to the growth in revenue and a decrease in days sales outstanding (“DSO”) during the three months ended March 31, 2026 as compared to the three months ended March 31, 2025. The related receivables due from the Illinois Department on Aging represented 23.1% and 18.5% of the Company’s net accounts receivable at March 31, 2026 and March 31, 2025, respectively.

Net cash used in investing activities for the three months ended March 31, 2026, primarily consisted of $1.7 million of cash used for property and equipment purchases, primarily related to our ongoing investments in technology infrastructure fixed assets. Net cash used in investing activities for the three months ended March 31, 2025 primarily consisted of $3.4 million of net cash used for the Jacksonville Acquisition and the Great Lakes Acquisition, $1.9 million of cash used for property and equipment purchases, primarily related to our ongoing investments in technology infrastructure fixed assets, offset by $3.8 million in proceeds received relating to the New York Asset Sale.

Net cash used in financing activities for the three months ended March 31, 2026, primarily consisted of $30.0 million payment on our revolving credit facility, offset by cash received from the exercise of stock options of $0.8 million. Net cash provided by financing activities for the three months ended March 31, 2025 primarily consisted of $20.0 million payment on our revolving credit facility, offset by cash received from the exercise of stock options of $0.5 million.

Outstanding Accounts Receivable

Outstanding accounts receivable, net of the allowance for credit losses as of March 31, 2026 and December 31, 2025 were approximately $144.8 million and $151.7 million, respectively, decreased by $6.9 million as of March 31, 2026 as compared to December 31, 2025. Accounts receivable for the Illinois Department on Aging decreased approximately $4.2 million during the three months ended March 31, 2026. Our collection procedures include review of account aging and direct contact with our payors. We have historically not used collection agencies. An uncollectible amount is written off to the allowance account after reasonable collection efforts have been exhausted.

We calculate our DSO by taking the trade accounts receivable outstanding, net of allowance for credit losses for doubtful accounts, divided by the net service revenues for the last quarter, multiplied by the number of days in that quarter. Our DSOs were 36 days and 38 days at March 31, 2026 and December 31, 2025, respectively. The DSOs for our largest payor, the Illinois Department on Aging, were 47 days and 55 days at March 31, 2026 and December 31, 2025, respectively.

Off-Balance Sheet Arrangements

As of March 31, 2026, we did not have any off-balance sheet guarantees or arrangements with unconsolidated entities.

Critical Accounting Policies and Estimates

There have been no material changes to our critical accounting policies and estimates previously disclosed under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies and Estimates” set forth in Part II, Item 7 of our Annual Report on Form 10-K for the period ended December 31, 2025, filed with the SEC.

Recently Issued Accounting Pronouncements

Refer to Note 2 to the Notes to Unaudited Condensed Consolidated Financial Statements for further discussion.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to market risk associated with changes in interest rates on our variable rate long-term debt. As of March 31, 2026, we had outstanding borrowings of approximately $94.3 million on our credit facility, all of such borrowings were subject to variable interest rates. If the variable rates on this debt were 100 basis points higher than the rate applicable to the borrowing during the three month period ended March 31, 2026, our net income would have decreased by $0.2 million, or $0.01 per diluted share. We do not currently have any derivative or hedging arrangements, or other known exposures, to changes in interest rates.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2026. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act, is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Based on the evaluation of our disclosure controls and procedures, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of March 31, 2026.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the fiscal quarter ended March 31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

Legal Proceedings

From time to time, we are subject to legal and/or administrative proceedings incidental to our business. It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on our financial position and results of operations.

Item 1A. Risk Factors

Investing in our common stock involves a high degree of risk. You should carefully consider the risk factors discussed under the caption “Risk Factors” set forth in Part I, Item 1A, of our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC. There have been no material changes to the risk factors previously disclosed under the caption “Risk Factors” in our Annual Report on Form 10-K. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, or operating results.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

During the quarter ended March 31, 2026, each of the following directors and Section 16 officers adopted a Rule 10b5-1 Trading Arrangement (as defined in Item 408(a) of Regulation S-K) to sell common shares:

				Shares Vesting and Subject to	Other Shares Being Sold
Name	Title	Adoption Date	Expiration Date (1)	Sell-To-Cover (2)	(Subject to Certain Conditions)
Roberton Stevenson	EVP and Chief Human Resources Officer	March 5, 2026	February 23, 2027	3,521	n/a
Michael Wattenbarger	EVP and Chief Information Officer	March 3, 2026	February 23, 2027	3,852	n/a
R. Dirk Allison	Chief Executive Officer and Chairman of the Board	March 2, 2026	February 23, 2027	32,492	n/a
Darby Anderson	EVP and Chief Government Affairs & Community Relations Officer	March 3, 2026	February 23, 2027	4,901	n/a
Heather Brianne Dixon	President and Chief Operating Officer	March 6, 2026	September 15, 2027	13,614	n/a
Cliff Blessing	EVP and Chief Development Officer	March 6, 2026	February 23, 2027	3,521	n/a
Brian Poff	EVP, Chief Financial Officer, Secretary and Treasurer	March 2, 2026	February 23, 2027	13,101	n/a
Monica Raines	EVP and Chief Compliance and Quality Officer	March 5, 2026	February 23, 2027	3,521	n/a
Sean Gaffney	EVP and Chief Legal Officer	March 5, 2026	February 23, 2027	4,901	n/a
David Tucker	EVP and Chief Strategy Officer	March 5, 2026	February 23, 2027	4,277	n/a

(1) Each plan will expire on the date represented in the table or upon the earlier completion of all transactions contemplated by the arrangement.

(2) This column indicates the total number of shares vesting in connection with equity awards, not the number of shares to be sold. The actual number of shares to be sold will be a smaller number based on whatever is required to satisfy payment of applicable withholding taxes under sell-to-cover arrangements.

Each trading arrangement noted above is intended to satisfy the affirmative defense in Rule 10b5-1(c). No other director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements, as such terms are defined in Item 408(a) of Regulation S-K, during the quarter ending March 31, 2026.

Table of Contents

Item 6. Exhibits

EXHIBIT INDEX

		Incorporated by Reference
Exhibit Number	Description of Document	Form	File No.	Date Filing	Exhibit Number

3.1	Amended and Restated Certificate of Incorporation of the Company dated as of October 27, 2009.	10-Q	001-34504	11/20/2009	3.1

3.2	Amended and Restated Bylaws of the Company, as amended by the First Amendment to the Amended and Restated Bylaws.	10-Q	001-34504	05/09/2013	3.2

4.1	Form of Common Stock Certificate.	S-1	333-160634	10/02/2009	4.1

31.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1	Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2	Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS	Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).

101.SCH	Inline XBRL Taxonomy Extension Schema Document.

101.CAL	Inline XBRL Taxonomy Calculation Linkbase Document.

101.LAB	Inline XBRL Taxonomy Label Linkbase Document.

101.PRE	Inline XBRL Presentation Linkbase Document.

101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document.

104	Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101).

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	*ADDUS HOMECARE CORPORATION*

Date: May 5, 2026	By:	/s/ R. DIRK ALLISON

		R. Dirk Allison Chairman and Chief Executive Officer (As Principal Executive Officer)

Date: May 5, 2026	By:	/s/ BRIAN POFF

		Brian Poff Chief Financial Officer (As Principal Financial Officer)

Addus HomeCare Corp 10-Q